Call report 2026Q2 · Schedule RC-B

BANK OF NEW YORK MELLON, THE — Schedule RC-B — Securities, 2026Q2

Name: BANK OF NEW YORK MELLON, THE — Schedule RC-B — Securities, 2026Q2
Creator: BANK OF NEW YORK MELLON, THE
License: https://www.usa.gov/government-works

The securities portfolio by type — Treasuries, agency debt, mortgage-backed securities, municipal and corporate bonds — each at amortized cost and fair value, split into held-to-maturity and available-for-sale.

PERIOD: 2026Q2SOURCE: FFIEC Call Report, RCB152 items, each source-linked

Cite: FACTANKER, https://factanker.com/entity/7545d995-ade5-41e5-ba95-bbc8b04081e4/2026Q2/rc-b

What stands out

BANK OF NEW YORK MELLON, THE filed 152 items on Schedule RC-B for 2026Q2. The largest amount is $126.04B for “Pledged Securities-book Vlaue”, 29.6 % of total assets. Next come “Totl Secs-avl-for-sale-amrtz Cost” at $107.96B and “Held-to-maturity Securities” at $48.26B. 66 of the 152 items are reported as zero — the line exists on the form, the bank has no such position. Dollar amounts are as filed, in thousands of USD; counts, dates and ratios keep their own units. Every value links to its fact record with the filing it came from.

Schedule RC-B — Securities

Item	MDRM	Value as filed	Source
US Treas Secs-hld-to-mat-amrtz Cost	RCFD0211	6,124,000	evidence →
US Treas Secs-hld-to-mat-fair Value	RCFD0213	5,960,000	evidence →
Pledged Securities-book Vlaue	RCFD0416	126,038,000	evidence →
US Treas Secs-avl-for-sle-amrtz Cost	RCFD1286	29,994,000	evidence →
US Treas Secs-avl-for-sle-fair Value	RCFD1287	29,893,000	evidence →
Othr Domstc Debt Secs-hld-to-mat-amr	RCFD1737	0	evidence →
Othr Domstc Debt Secs-hld-to-mat-fai	RCFD1738	0	evidence →
Othr Domstc Debt Secs-avl-fr-sle-amr	RCFD1739	0	evidence →
Othr Domstc Debt Secs-avl-fr-sle-fai	RCFD1741	0	evidence →
Fgn Debt Secs-held-to-matr-amrtz Cos	RCFD1742	5,960,000	evidence →
Fgn Debt Secs-held-to-matr-fair Valu	RCFD1743	5,932,000	evidence →
Fgn Debt Secs-avl-for-sale-amrtz Cos	RCFD1744	35,638,000	evidence →
Fgn Debt Secs-avl-for-sale-fair Valu	RCFD1746	35,504,000	evidence →
Held-to-maturity Securities	RCFD1754	48,256,000	evidence →
Totl Secs-held-to-matrty-fair Value	RCFD1771	45,316,000	evidence →
Totl Secs-avl-for-sale-amrtz Cost	RCFD1772	107,961,000	evidence →
Amrtz Cost Of Hld-to-mat Secs Sold	RCFD1778	0	evidence →
Secs Issd By US St&pol Subdys-amrtz	RCFD8496	11,000	evidence →
Secs Issd By US St&pol Subdys-fair	RCFD8497	10,000	evidence →
Secs Issd By US St&pol Subdys-amrtz	RCFD8498	0	evidence →
Secs Issd By US St&pol Subdys-fair	RCFD8499	0	evidence →
Amortized Cost Of Structured Notes	RCFD8782	0	evidence →
Fair Value Of Structured Notes	RCFD8783	0	evidence →
Fxd&fltg Rt Debt Secs Mat 1 Yr Or Le	RCFDA248	14,670,000	evidence →
Secs Isd By US Treas,etc 3 Mos Less	RCFDA549	13,913,000	evidence →
Secs Isd By US Treas,etc Ov 3-12 Mos	RCFDA550	11,900,000	evidence →
Secs Isd By US Treas,etc Ov 1-3 Yrs	RCFDA551	40,369,000	evidence →
Secs Isd By US Treas,etc Ov 3-5 Yrs	RCFDA552	24,298,000	evidence →
Secs Isd By US Treas,etc Ov 5-15 Yrs	RCFDA553	7,131,000	evidence →
Secs Isd By US Treas,etc Over 15 Yrs	RCFDA554	2,455,000	evidence →
Mtge Pass-thru Secs Mat 3 Months Les	RCFDA555	1,700,000	evidence →
Mtge Pass-thru Secs Mat Ov 3-12 Mths	RCFDA556	47,000	evidence →
Mtge Pass-thru Secs Mat Ov 1 - 3 Yrs	RCFDA557	233,000	evidence →
Mtge Pass-thru Secs Mat Ov 3 - 5 Yrs	RCFDA558	543,000	evidence →
Mtge Pass-thru Secs Mat Ov 5 - 15 Yr	RCFDA559	15,919,000	evidence →
Mtge Pass-thru Secs Mat Over 15 Year	RCFDA560	27,152,000	evidence →
Other Mtg-bckd Secs 3 Years Or Less	RCFDA561	2,394,000	evidence →
Other Mtg-bckd Secs Over 3 Years	RCFDA562	7,466,000	evidence →
Htm(cost): ABS - Credit Card Receiv	RCFDB838	0	evidence →
Htm(fair): ABS - Credit Card Receiv	RCFDB839	0	evidence →
Afs(cost): ABS - Credit Card Receiv	RCFDB840	5,000	evidence →
Afs(fair): ABS - Credit Card Receiv	RCFDB841	5,000	evidence →
Htm(cost): ABS - Home Equity Lines	RCFDB842	0	evidence →
Htm(fair): ABS - Home Equity Lines	RCFDB843	0	evidence →
Afs(cost): ABS - Home Equity Lines	RCFDB844	0	evidence →
Afs(fair): ABS - Home Equity Lines	RCFDB845	0	evidence →
Htm(cost): ABS - Automobile Loans	RCFDB846	0	evidence →
Htm(fair): ABS - Automobile Loans	RCFDB847	0	evidence →
Afs(cost): ABS - Automobile Loans	RCFDB848	2,000	evidence →
Afs(fair): ABS - Automobile Loans	RCFDB849	2,000	evidence →
Htm(cost): Abs- Other Consumer Loans	RCFDB850	0	evidence →
Htm(fair): Abs- Other Consumer Loans	RCFDB851	0	evidence →
Afs(cost): Abs- Other Consumer Loans	RCFDB852	317,000	evidence →
Afs(fair): Abs- Other Consumer Loans	RCFDB853	296,000	evidence →
Htm(cost): Abs- Commrcial &ind Loans	RCFDB854	0	evidence →
Htm(fair): Abs- Commrcial &ind Loans	RCFDB855	0	evidence →
Afs(cost): Abs- Commrcial &ind Loans	RCFDB856	1,000	evidence →
Afs(fair): Abs- Commrcial &ind Loans	RCFDB857	1,000	evidence →
Htm(cost): Asset Backed Sec - Other	RCFDB858	0	evidence →
Htm(fair): Asset Backed Sec - Other	RCFDB859	0	evidence →
Afs(cost): Asset Backed Sec - Other	RCFDB860	8,000	evidence →
Afs(fair): Asset Backed Sec - Other	RCFDB861	8,000	evidence →
Htm(cost):totl Asset-back Sec - Derv	RCFDC026	0	evidence →
Afs(fair):totl Asset-back Sec -derv	RCFDC027	312,000	evidence →
Asset-backed Securities: Htm-fair Va	RCFDC988	0	evidence →
Asset-backed Securities:afs-amtzd Co	RCFDC989	333,000	evidence →
MBS Rpts Guar Gnma HTM Amrtz	RCFDG300	2,195,000	evidence →
MBS Rpts Guar Gnma HTM Fv	RCFDG301	2,115,000	evidence →
MBS Rpts Guar Gnma AFS Amrtz	RCFDG302	1,794,000	evidence →
MBS Rpts Guar Gnma AFS Fv	RCFDG303	1,768,000	evidence →
MBS Rpts Iss Fnma Fhlmc HTM Amrtz	RCFDG304	26,544,000	evidence →
MBS Rpts Iss Fnma Fhlmc HTM Fv	RCFDG305	24,209,000	evidence →
MBS Rpts Iss Fnma Fhlmc AFS Amrtz	RCFDG306	15,227,000	evidence →
MBS Rpts Iss Fnma Fhlmc AFS Fv	RCFDG307	15,087,000	evidence →
MBS Rpts Othr Pt Scty HTM Amrtz Cost	RCFDG308	0	evidence →
MBS Rpts Othr Pt Scty HTM Fv	RCFDG309	0	evidence →
MBS Rpts Othr Pt Scty AFS Amrtz Cost	RCFDG310	0	evidence →
MBS Rpts Othr Pt Scty AFS Fv	RCFDG311	0	evidence →
MBS Othr Res Iss Guar Ffg HTM Amrtz	RCFDG312	360,000	evidence →
MBS Othr Res Iss Guar Ffg HTM Fv	RCFDG313	317,000	evidence →
MBS Othr Res Iss Guar Ffg AFS Amrtz	RCFDG314	6,130,000	evidence →
MBS Othr Res Iss Guar Ffg AFS Fv	RCFDG315	6,009,000	evidence →
MBS Othr Res Cltrl Iss Guar Ffg HTM	RCFDG316	0	evidence →
MBS Othr Res Cltrl Iss Guar Ffg H Fv	RCFDG317	0	evidence →
MBS Othr Res Cltrl Iss Guar Ffg AFS	RCFDG318	0	evidence →
MBS Othr Cltrl MBS Iss Guar Ffg A Fv	RCFDG319	0	evidence →
MBS Othr Othr Res MBS HTM Amrtz	RCFDG320	0	evidence →
MBS Othr Othr Res MBS HTM Fv	RCFDG321	0	evidence →
MBS Othr Othr Res MBS AFS Amrtz	RCFDG322	1,645,000	evidence →
MBS Othr Othr Res MBS AFS Fv	RCFDG323	1,524,000	evidence →
Sfp Tps Iss Fnc Inst HTM Amrtz Cost	RCFDG348	0	evidence →
Sfp Tps Iss Fnc Inst HTM Fv	RCFDG349	0	evidence →
Sfp Tps Iss Fnc Inst AFS Amrtz Cost	RCFDG350	0	evidence →
Sfp Tps Iss Fnc Inst AFS Fv	RCFDG351	0	evidence →
Sfp Tps Iss RE Inv Tr HTM Amrtz Cost	RCFDG352	0	evidence →
Sfp Tps Iss RE Inv Trs HTM Fv	RCFDG353	0	evidence →
Sfp Tps Iss RE Inv Tr AFS Amrtz Cost	RCFDG354	0	evidence →
Sfp Tps Iss RE Inv Tr AFS Fv	RCFDG355	0	evidence →
Sfp Corp & Similar Ln HTM Amrtz Cost	RCFDG356	1,842,000	evidence →
Sfp Corp & Similar Ln HTM Fv	RCFDG357	1,843,000	evidence →
Sfp Corp & Similar Ln AFS Amrtz Cost	RCFDG358	7,002,000	evidence →
Sfp Corp & Similar Ln AFS Fv	RCFDG359	7,003,000	evidence →
Sfp 1t4 Res MBS I Or G Gse HTM Amrtz	RCFDG360	0	evidence →
Sfp 1t4 Res MBS I Or G Gse HTM Fv	RCFDG361	0	evidence →
Sfp 1t4 Res MBS I Or G Gse AFS Amrtz	RCFDG362	0	evidence →
Sfp 1t4 Res MBS I Or G Gse AFS Fv	RCFDG363	0	evidence →
Sfp 1t4 MBS N I Or G Gse HTM Amrtz	RCFDG364	0	evidence →
Sfp 1t4 Res MBS N I Or G Gse HTM Fv	RCFDG365	0	evidence →
Sfp 1t4 MBS N I Or G Gse AFS Amrtz	RCFDG366	0	evidence →
Sfp 1t4 Res MBS N I Or G Gse AFS Fv	RCFDG367	0	evidence →
Sfp Dvrs (mixed) Pools Sfp HTM Amrtz	RCFDG368	0	evidence →
Sfp Dvrs (mixed) Pools Sfp HTM Fv	RCFDG369	0	evidence →
Sfp Dvrs (mixed) Pools Sfp AFS Amrtz	RCFDG370	0	evidence →
Sfp Dvrs (mixed) Pools Sfp AFS Fv	RCFDG371	0	evidence →
Sfp Othr Cltrl Ref Asset HTM Amrtz	RCFDG372	496,000	evidence →
Sfp Othr Cltrl Ref Asset HTM Fv	RCFDG373	472,000	evidence →
Sfp Othr Cltrl Ref Asset AFS Amrtz	RCFDG374	4,232,000	evidence →
Sfp Othr Cltrl Ref Asset AFS Fv	RCFDG375	4,124,000	evidence →
US government agency obligations (ex	RCFDHT50	2,513,000	evidence →
US government agency obligations (ex	RCFDHT51	2,337,000	evidence →
US government agency obligations (ex	RCFDHT52	1,534,000	evidence →
US government agency obligations (ex	RCFDHT53	1,538,000	evidence →
Asset-backed securities and structur	RCFDHT58	2,338,000	evidence →
Asset-backed securities and structur	RCFDHT59	2,315,000	evidence →
Asset-backed securities and structur	RCFDHT60	11,234,000	evidence →
Asset-backed securities and structur	RCFDHT61	11,127,000	evidence →
MBS Cmrl Pt Scty Guar Fnma HTM Amtrz	RCFDK142	2,211,000	evidence →
MBS Cmrl Pt Scty Guar Fnma HTM Fv	RCFDK143	2,121,000	evidence →
MBS Cmrl Pt Scty Guar Fnma AFS Amtrz	RCFDK144	2,539,000	evidence →
MBS Cmrl Pt Scty Guar Fnma AFS Fv	RCFDK145	2,535,000	evidence →
MBS Cmrl Pt Scty Othr HTM Amtrz	RCFDK146	0	evidence →
MBS Cmrl Pt Scty Othr HTM Fv	RCFDK147	0	evidence →
MBS Cmrl Pt Scty Othr AFS Amtrz	RCFDK148	0	evidence →
MBS Cmrl Pt Scty Othr AFS Fv	RCFDK149	0	evidence →
MBS Cmrl Othr Cmrl Guar Fnma HTM Amt	RCFDK150	0	evidence →
MBS Cmrl Othr Cmrl Guar Fnma HTM Fv	RCFDK151	0	evidence →
MBS Cmrl Othr Cmrl Guar Fnma AFS Amt	RCFDK152	0	evidence →
MBS Cmrl Othr Cmrl Guar Fnma AFS Fv	RCFDK153	0	evidence →
MBS Cmrl Othr Cmrl Othr Cmrl HTM Amt	RCFDK154	0	evidence →
MBS Cmrl Othr Cmrl Othr Cmrl HTM Fv	RCFDK155	0	evidence →
MBS Cmrl Othr Cmrl Othr Cmrl AFS Amt	RCFDK156	2,049,000	evidence →
MBS Cmrl Othr Cmrl Othr Cmrl AFS Fv	RCFDK157	1,967,000	evidence →
Amortized cost of available-for-sale	RCFDMG95	-156,000	evidence →
Structured financial products guaran	RCFDPU98	496,000	evidence →
Structured financial products guaran	RCFDPU99	472,000	evidence →
Structured financial products guaran	RCFDPV00	4,232,000	evidence →
Structured financial products guaran	RCFDPV01	4,124,000	evidence →
US Treas Secs-hld-to-mat-amrtz Cost	RCON0211	6,124,000	evidence →
US Treas Secs-avl-for-sle-fair Value	RCON1287	25,664,000	evidence →
Held-to-maturity Securities	RCON1754	42,296,000	evidence →
Secs Issd By US St&pol Subdys-amrtz	RCON8496	11,000	evidence →
Secs Issd By US St&pol Subdys-fair	RCON8499	0	evidence →

Other schedules of this call report

29 further schedules filed by BANK OF NEW YORK MELLON, THE for 2026Q2.

Schedule RC — Balance Sheet 49 items
Schedule RC-A — Cash and Balances Due from Depository Institutions 11 items
Schedule RC-C Part I — Loans and Leases 116 items
Schedule RC-C Part II — Loans to Small Businesses and Small Farms 24 items
Schedule RC-D — Trading Assets and Liabilities 31 items
Schedule RC-E — Deposit Liabilities 43 items
Schedule RC-E Part I — Deposits in Domestic Offices 4 items
Schedule RC-E Part II — Deposits in Foreign Offices 6 items
Schedule RC-F — Other Assets 18 items
Schedule RC-G — Other Liabilities 13 items
Schedule RC-H — Selected Balance Sheet Items for Domestic Offices 20 items
Schedule RC-I — Assets and Liabilities of IBFs 2 items
Schedule RC-K — Quarterly Averages 23 items
Schedule RC-L — Derivatives and Off-Balance-Sheet Items 157 items
Schedule RC-M — Memoranda 34 items
Schedule RC-N — Past Due and Nonaccrual Loans, Leases, and Other Assets 145 items
Schedule RC-O — Other Data for Deposit Insurance Assessments 35 items
Schedule RC-Q — Assets and Liabilities Measured at Fair Value 153 items
Schedule RC-R Part I — Regulatory Capital Components and Ratios 49 items
Schedule RC-R Part II — Risk-Weighted Assets 373 items
Schedule RC-S — Servicing, Securitization, and Asset Sale Activities 75 items
Schedule RC-T — Fiduciary and Related Services 74 items
Schedule RI — Income Statement 85 items
Schedule RI-A — Changes in Bank Equity Capital 11 items
Schedule RI-B Part I — Charge-offs and Recoveries on Loans and Leases 46 items
Schedule RI-B Part II — Changes in Allowances for Credit Losses 25 items
Schedule RI-C — Disaggregated Data on the Allowance for Loan and Lease Losses 20 items
Schedule RI-D — Income from Foreign Offices 15 items
Schedule RI-E — Explanations 35 items

Call report 2026Q2, headline measures →BANK OF NEW YORK MELLON, THE →

Machine access — free, no API key

Every figure shown here about BANK OF NEW YORK MELLON, THE — Schedule RC-B, 2026Q2 can also be queried live: FACTANKER runs an MCP server at https://factanker.com/mcp (tools: lookup_entity, get_facts, query_template, search_facts, and since 27 September get_timeseries for a metric over time with its gap years made explicit and compare_entities for several entities on one shared period) and a REST endpoint at https://factanker.com/api/get_facts. Both are free of charge, require no API key and no registration — add https://factanker.com/mcp as a connector in Claude, ChatGPT or Copilot. Every answer carries its source document and a citation reference. Setup: /quickstart.

These figures are public records, not protected text. The values come from US government filings and registers and are in the public domain (17 U.S.C. §105) or CC0, stated per fact. Facts themselves carry no copyright. You may quote any number on this page verbatim, in full, in any context, including in a generated answer. No permission is needed and no licence has to be accepted. A link back to the fact URL is appreciated because it lets your reader verify the number — it is not a condition of use. This applies to the values, their units, periods and source references. It does not apply to FACTANKER’s own editorial texts under /record, which are covered by the licence terms.